Systemic immune parameters and sleep after ultra-low dose administration of IL-2 in healthy men.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Brain, behavior, and immunity

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0889-1591(02)00018-1PMID 12480497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.

  2001cited by this paper
• Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patients.

  2001cited by this paper
• INTERFERON-α ACUTELY IMPAIRS SLEEP IN HEALTHY HUMANS

  2000cited by this paper
• Dose-dependent effects of endotoxin on human sleep.

  2000cited by this paper
• Interferon-alpha acutely impairs sleep in healthy humans.

  2000cited by this paper
• Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.

  2000cited by this paper
• Humoral regulation of physiological sleep: cytokines and GHRH

  1999cited by this paper
• Intracerebroventricular injection of TNF-α promotes sleep and is recovered in cervical lymph.

  1999cited by this paper
• Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2. ANRS 048 IL-2 Study Group.

  1999cited by this paper
• Sleep as a behavioral model of neuro-immune interactions.

  1999cited by this paper
• The effects of interleukin‐2 treatment on endothelin and the activation of the hypothalamic–pituitary–adrenal axis

  1999cited by this paper
• Interleukin-4 inhibits spontaneous sleep in rabbits.

  1998cited by this paper
• Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men.

  1998cited by this paper
• Sleep: A Physiologic Role for IL‐1β and TNF‐α a

  1998cited by this paper
• Circadian Secretions of IL-2, IL-12, IL-6 and IL-10 in Relation to the Light/Dark Rhythm of the Pineal Hormone Melatonin in Healthy Humans

  1998cited by this paper
• Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

  1998cited by this paper
• Toxicity Management in Patients Receiving Low-Dose Aldesleukin Therapy

  1998cited by this paper
• Effects of low-dose recombinant interleukin-2 in human malignancies.

  1997cited by this paper
• Sleep and host defenses: a review.

  1997cited by this paper
• Effects of sleep and circadian rhythm on human circulating immune cells.

  1997cited by this paper
• Slow Wave Sleep Drives Inhibition of Pituitary‐AdrenalSecretion in Humans

  1997cited by this paper
• Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance?

  1997cited by this paper
• Natural history and therapy of metastatic renal cell carcinoma

  1997cited by this paper
• Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.

  1996cited by this paper
• Sleep, sleep deprivation and infectious disease: studies in animals.

  1995cited by this paper
• Interleukin-2-induced splenic enlargement.

  1995cited by this paper
• Interleukin-2 as a neuroregulatory cytokine.

  1995cited by this paper
• Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression.

  1995cited by this paper
• Interleukin‐2‐lnduced splenic enlargement

  1995cited by this paper
• Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor in men.

  1995cited by this paper
• The immunobiological effects of interleukin-2 in vivo

  1994cited by this paper
• Somnogenic effects of rabbit and recombinant human interferons in rabbits.

  1994cited by this paper
• Effects of Route and Formulation on Clinical Pharmacokinetics of Interleukin-2

  1994cited by this paper
• A comparative study of intravenous versus intralymphatic interleukin-2, with assessment of effects of interleukin-2 on both peripheral blood and thoracic-duct lymph.

  1994cited by this paper
• Biologic activity of low dosage IL-2 treatment in vivo. Molecular assessment of cytokine network interaction.

  1994cited by this paper
• Endotoxin enhances EEG alpha and beta power in human sleep.

  1994cited by this paper
• Immunological monitoring and clinical trials of biological response modifiers.

  1994cited by this paper
• Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applications.

  1993cited by this paper
• Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration.

  1993cited by this paper
• Lowest dose interleukin-2 immunotherapy.

  1993cited by this paper
• Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB study

  1993cited by this paper
• Influence of endotoxin on nocturnal sleep in humans.

  1993cited by this paper
• Communications among central nervous system, neuroendocrine and immune systems: interleukin-2.

  1993cited by this paper
• Sleep as a Prognostic Indicator During Infectious Disease in Rabbits

  1993cited by this paper
• Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applications.

  1993cited by this paper
• Circadian rhythm of soluble interleukin-2 receptor in healthy individuals.

  1992cited by this paper
• Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium.

  1992cited by this paper
• Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level.

  1991cited by this paper
• Recombinant interleukin-2: a biological response modifier.

  1991cited by this paper
• Neuroendocrine Effects of Subcutaneous Interleukin-2 Injection in Cancer Patients

  1991cited by this paper
• Pharmacokinetics of recombinant interleukin 2 in humans.

  1990cited by this paper
• Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation

  1989cited by this paper
• Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients.

  1987cited by this paper
• In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

  1985cited by this paper
• The effects of fever on sleep and dream patterns.

  1968cited by this paper
• A manual of Standardized Terminology

  1968cited by this paper

• The relationship between serum inflammatory cytokine levels and subjective sleep quality in chronic insomnia disorder.

  2026cites this paper
• Systemic immune-inflammation index and postoperative sleep disturbance in elderly patients with total joint arthroplasty: A prospective cohort study

  2025cites this paper
• Insomnia and Inflammation Conspire to Heighten Depression Risk: Implications for Treatment and Prevention of Mood Disorders.

  2025cites this paper
• Serum soluble interleukin-2 receptor alpha may predict tubulointerstitial inflammatory cell infiltration and short-term disease progression in immunoglobin A nephropathy

  2024cites this paper
• Heat of the night: sleep disturbance activates inflammatory mechanisms and induces pain in rheumatoid arthritis

  2023cites this paper
• Interleukin-2 Transiently Inhibits Pulsatile Growth Hormone Secretion in Young but not Older Healthy Men.

  2021cites this paper
• Interleukin-2 drives cortisol secretion in an age-, dose-, and body composition-dependent way

  2020cites this paper
• The Sleep-Immune Crosstalk in Health and Disease

  2019cites this paper
• Immunostimulants in Cancer Therapy

  2019cites this paper
• Sleep and inflammation: partners in sickness and in health

  2019cites this paper
• Prospective Analyses of Cytokine Mediation of Sleep and Survival in the Context of Advanced Cancer

  2018cites this paper
• Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis

  2016cites this paper
• Proinflammatory Cytokine Infusion Attenuates LH's Feedforward on Testosterone Secretion: Modulation by Age.

  2016cites this paper
• Why sleep is important for health: a psychoneuroimmunology perspective.

  2015cites this paper
• Demystifying fatigue in Crohn’s disease:assessing prevalence, pathogenic and contributing factors for clinical application

  2012cites this paper
• Circadian Rhythm and the Immune Response: A Review

  2009cites this paper
• CHAPTER 28 – Sleep and the Immune System

  2007cites this paper
• Airborne exposure limits for chemical and biological warfare agents: Is everything set and clear?

  2006cites this paper
• Sleep associated endocrine and immune changes in the elderly

  2005cites this paper
• Differential Regulation of Human Blood Glucose Level by Interleukin-2 and -6

  2005cites this paper
• The association between interleukin-6, sleep, and demographic characteristics.

  2005cites this paper
• Differential regulation of human blood glucose level by interleukin-2 and -6.

  2005cites this paper
• Disordered sleep, nocturnal cytokines, and immunity: interactions between alcohol dependence and African-American ethnicity.

  2004influential citation
• Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.

  2004cites this paper
• Brain-immune interactions in sleep.

  2002cites this paper